ILIsis Claire Zhen Yu Lim

Isis Claire Zhen Yu Lim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Isis Claire Zhen Yu Lim has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Meta‐analysis of multi‐modality therapies in sinonasal undifferentiated carcinoma—A timely update

    by Alicia Su Yun See, Clarisse Chu, Isis Claire Zhen Yu Lim, Benjamin Kye Jyn Tan, Sheryl Xiu Qi Ang, Shuhui Xu, Neville Wei Yang Teo, Tze Choong Charn

    Objectives: Sinonasal undifferentiated carcinoma (SNUC) is a rare but aggressive tumour with very poor prognosis. There are currently no well-established clinical trials to guide therapy and the impact of various treatment modalities on survival is not well defined. We aim to provide an updated systematic review on current treatment modalities on survival outcomes.Design and Setting: Individual patient data were extracted, and survival data pooled in a one-stage meta-analysis. Descriptive statistics were analysed using the Kaplan-Meier method. Patient-level comparisons stratified by treatment modalities, adjusted for demographics, were conducted using shared-frailty Cox regression.Participants and Main outcome measures: Participants include all patients diagnosed with SNUC based on histological evidence. We looked at the overall cumulative survival outcome for different treatment modalities and overall survival by treatment modality in low versus high stage SNUC patients.Results and Conclusion: Seventeen studies were identified, comprising 208 patients from 1993 to 2020. There was no significant difference in cumulative overall survival in low versus high stage patients, and no significant difference in outcomes by treatment modality. The overall cumulative survival of SNUC is 30% at 95 months. Among patients treated with various combinations of treatment modalities, patients with chemoradiotherapy had the highest cumulative survival of 42% at 40 months. Definitive chemoradiotherapy was associated with improved disease survival rate. Regardless of tumour stage, patients should be treated early and aggressively, with no superiority of one treatment regimen over another. Trimodality treatment does not confer survival advantage over bimodality treatment.


  • Parakinesia Brachialis Oscitans: Old Sign, New Findings

    by Isis Claire Z.Y. Lim, Shermyn Neo


  • Predicting Clinical Outcomes in Acute Ischemic Stroke Patients Undergoing Endovascular Thrombectomy with Machine Learning

    by Yao Hao Teo, Isis Claire Z. Y. Lim, Fan Shuen Tseng, Yao Neng Teo, Cheryl Shumin Kow, Zi Hui Celeste Ng, Nyein Chan Ko Ko, Ching-Hui Sia, Aloysius S. T. Leow, Wesley Yeung, et al.

    Purpose Conventional predictive models are based on a combination of clinical and neuroimaging parameters using traditional statistical approaches. Emerging studies have shown that the machine learning (ML) prediction models with multiple pretreatment clinical variables have the potential to accurately prognosticate the outcomes in acute ischemic stroke (AIS) patients undergoing thrombectomy, and hence identify patients suitable for thrombectomy. This article summarizes the published studies on ML models in large vessel occlusion AIS patients undergoing thrombectomy. Methods We searched electronic databases including PubMed from 1 January 2000 up to 14 October 2019 for studies that evaluated ML algorithms for the prediction of outcomes in stroke patients undergoing thrombectomy. We then used random-effects bivariate meta-analysis models to summarize the studies. Results We retained a total of five studies that evaluated ML (4 support vector machine, 1 decision tree model) with a combined cohort of 802 patients. The prevalence of good functional outcome defined by 90-day mRS of 0–2 when available. Random effects model demonstrated that the AUC was 0.846 (95% confidence interval, CI 0.686–0.902). A pooled diagnostic odds ratio of 12.6 was computed. The pooled sensitivity and specificity were 0.795 (95% CI 0.651–0.889) and 0.780 (95% CI 0.634–0.879), respectively. Conclusion ML may be useful as an adjunct to clinical assessment to predict functional outcomes in AIS patients undergoing thrombectomy, and hence identify suitable patients for treatment. Further studies validating ML models in large multicenter cohorts are necessary to explore this further.